Literature DB >> 11096762

Rabies.

.   

Abstract

Human rabies is fatal except in the small number of patients who received rabies immunization before the onset of clinical rabies. Therapy has been futile in all other cases once rabies has developed. Rabies is always preventable after an exposure if current recommendations are followed. After a potential rabies exposure, details about the contact, the animal, and the local epidemiologic situation are important in making a decision whether to initiate postexposure prophylaxis (PEP). Rabies PEP includes thorough local wound cleansing and both active and passive immunization. Five doses of rabies vaccine should be administered intramuscularly in the deltoid muscle on days 0, 3, 7, 14, and 28 in individuals previously unimmunized against rabies virus. Human rabies immune globulin (20 IU/kg) should be given on day 0 with administration into and around the wounds; the remaining volume is given intramuscularly at a site distant from the vaccine site. Certain individuals at high risk for rabies exposure are candidates for preexposure prophylaxis with three doses of rabies vaccine. Booster doses should be given as required.

Entities:  

Year:  2000        PMID: 11096762     DOI: 10.1007/s11940-000-0054-6

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  24 in total

1.  The long incubation period in rabies: delayed progression of infection in muscle at the site of exposure.

Authors:  K M Charlton; S Nadin-Davis; G A Casey; A I Wandeler
Journal:  Acta Neuropathol       Date:  1997-07       Impact factor: 17.088

Review 2.  Article I: Prevention and education regarding rabies in human beings. National Working Group on Rabies Prevention and Control.

Authors:  C A Hanlon; J G Olson; C J Clark
Journal:  J Am Vet Med Assoc       Date:  1999-11-01       Impact factor: 1.936

3.  A case of human rabies with prolonged survival.

Authors:  R W Emmons; L L Leonard; F DeGenaro; E S Protas; P L Bazeley; S T Giammona; K Sturckow
Journal:  Intervirology       Date:  1973       Impact factor: 1.763

4.  Partial recovery from rabies in a nine-year-old boy.

Authors:  L Alvarez; R Fajardo; E Lopez; R Pedroza; T Hemachudha; N Kamolvarin; G Cortes; G M Baer
Journal:  Pediatr Infect Dis J       Date:  1994-12       Impact factor: 2.129

5.  Systemic allergic reactions following immunization with human diploid cell rabies vaccine.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1984-04-13       Impact factor: 17.586

6.  Human rabies prevention--United States, 1999. Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors: 
Journal:  MMWR Recomm Rep       Date:  1999-01-08

7.  Studies on the local treatment of wounds for the prevention of rabies.

Authors:  M M KAPLAN; D COHEN; H KOPROWSKI; D DEAN; L FERRIGAN
Journal:  Bull World Health Organ       Date:  1962       Impact factor: 9.408

8.  Is the acetylcholine receptor a rabies virus receptor?

Authors:  T L Lentz; T G Burrage; A L Smith; J Crick; G H Tignor
Journal:  Science       Date:  1982-01-08       Impact factor: 47.728

9.  Risk factors for systemic hypersensitivity reactions after booster vaccinations with human diploid cell rabies vaccine: a nationwide prospective study.

Authors:  D B Fishbein; K M Yenne; D W Dreesen; C F Teplis; N Mehta; D J Briggs
Journal:  Vaccine       Date:  1993-11       Impact factor: 3.641

10.  Clinical experience with a human diploid cell rabies vaccine.

Authors:  L J Anderson; W G Winkler; B Hafkin; R A Keenlyside; L J D'Angelo; M W Deitch
Journal:  JAMA       Date:  1980 Aug 22-29       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.